Masahito Ebina
Sendai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
The providing multidisciplinary ILD diagnoses (PROMISE) study - study design of the national registry of Japan facilitating interactive online multidisciplinary discussion diagnosis.
Journal: BMC pulmonary medicine
Published: May 06, 2024
Serum surfactant protein D as a predictive biomarker for the efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of the phase 3 trial in Japan.
Journal: Respiratory research
Published: July 27, 2020
Intractable diffuse pulmonary diseases: Manual for diagnosis and treatment.
Journal: Respiratory investigation
Published: January 23, 2020
Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled Trial.
Journal: American journal of respiratory and critical care medicine
Published: January 10, 2020
Improvement of native pulmonary alveolar proteinosis after contralateral single living-donor lobar lung transplantation: A case report.
Journal: Pediatric transplantation
Published: October 07, 2019
Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan.
Journal: ERJ open research
Published: July 25, 2019
Japanese guideline for the treatment of idiopathic pulmonary fibrosis.
Journal: Respiratory investigation
Published: December 26, 2017
A Semiquantitative Computed Tomographic Grading System for Evaluating Therapeutic Response in Pulmonary Alveolar Proteinosis.
Journal: Annals of the American Thoracic Society
Published: May 11, 2017
What factors determine the survival of patients with an acute exacerbation of interstitial lung disease after lung cancer resection?
Journal: Surgery today
Published: April 26, 2017
Last Updated: 09/26/2026